| Primary |
| Conjunctivitis Allergic |
33.3% |
| Nasal Congestion |
33.3% |
| Ophthalmological Examination |
33.3% |
|
| Breast Cancer |
50.0% |
| Psychotic Disorder |
50.0% |
|
| Secondary |
| Foetal Exposure During Pregnancy |
19.6% |
| Pruritus |
10.3% |
| Rash |
10.3% |
| Rheumatoid Arthritis |
9.3% |
| Hypertension |
6.1% |
| Asthma |
5.6% |
| Rhinitis Allergic |
4.7% |
| Erythema |
3.7% |
| Osteoarthritis |
3.7% |
| Product Used For Unknown Indication |
3.3% |
| Tinea Infection |
3.3% |
| Cardiac Failure |
2.8% |
| Drug Eruption |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Otitis Media Acute |
2.3% |
| Antitussive Therapy |
1.9% |
| Cardiovascular Disorder |
1.9% |
| Diuretic Therapy |
1.9% |
| Hyperlipidaemia |
1.9% |
| Oedema Peripheral |
1.9% |
|
| Cerebellar Infarction |
12.9% |
| Alanine Aminotransferase Increased |
9.7% |
| Renal Impairment |
9.7% |
| Cleft Palate |
6.5% |
| Eyelid Oedema |
6.5% |
| Laceration |
6.5% |
| Myocardial Ischaemia |
6.5% |
| Activated Partial Thromboplastin Time Prolonged |
3.2% |
| Bilirubin Conjugated Increased |
3.2% |
| Blood Fibrinogen Decreased |
3.2% |
| Body Dysmorphic Disorder |
3.2% |
| Decreased Appetite |
3.2% |
| Developmental Delay |
3.2% |
| Dyspnoea |
3.2% |
| Eosinophilia |
3.2% |
| Faeces Pale |
3.2% |
| Glaucoma |
3.2% |
| Granulocytopenia |
3.2% |
| Hepatic Function Abnormal |
3.2% |
| Interstitial Lung Disease |
3.2% |
|
| Concomitant |
| Hepatitis C |
18.6% |
| Product Used For Unknown Indication |
12.6% |
| Prophylaxis |
9.7% |
| Psoriasis |
8.1% |
| Acute Lymphocytic Leukaemia |
8.0% |
| Hypertension |
7.4% |
| Psoriatic Arthropathy |
5.2% |
| Rheumatoid Arthritis |
3.4% |
| Colorectal Cancer |
3.2% |
| Febrile Neutropenia |
3.2% |
| Dermatitis Atopic |
3.0% |
| Asthma |
2.7% |
| Insomnia |
2.3% |
| Pruritus |
2.3% |
| Type 2 Diabetes Mellitus |
1.8% |
| Adult T-cell Lymphoma/leukaemia |
1.8% |
| Erythema Multiforme |
1.8% |
| Multiple Myeloma |
1.8% |
| Constipation |
1.7% |
| Helicobacter Gastritis |
1.6% |
|
| Anaemia |
8.7% |
| Neutrophil Count Decreased |
8.7% |
| Rash |
8.7% |
| Renal Impairment |
7.9% |
| Hepatic Function Abnormal |
6.3% |
| Pneumonia |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Drug Eruption |
4.8% |
| Inappropriate Antidiuretic Hormone Secretion |
4.8% |
| Thyroid Cancer |
4.8% |
| Convulsion |
4.0% |
| Fracture |
4.0% |
| Vomiting |
4.0% |
| Blood Creatine Phosphokinase Increased |
3.2% |
| Blood Pressure Decreased |
3.2% |
| Death |
3.2% |
| Delirium |
3.2% |
| Dermatitis Exfoliative |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Rash Papular |
3.2% |
|
| Interacting |
| Dysmenorrhoea |
50.0% |
| Seasonal Allergy |
50.0% |
|
|
